Search results for "Evidence"

showing 10 items of 1050 documents

Bone mineral density, osteoporosis, and fractures among people with eating disorders: a systematic review and meta-analysis

2016

Objective: To provide meta-analytical evidence of bone mineral density (BMD), fractures, and osteoporosis rates in eating disorders (ED) vs. healthy controls (HCs). Method: Three independent authors searched major electronic databases from inception till August 2015 for cross-sectional studies reporting BMD in people with ED (anorexia nervosa, (AN); bulimia nervosa, (BN); eating disorders not otherwise specified, (EDNOS)) vs. HCs. Standardized mean differences (SMDs) ±95% and confidence intervals (CIs) were calculated for BMD, and odds ratios (ORs) for osteopenia, osteoporosis, and fractures. Results: Overall, 57 studies were eligible, including 21 607 participants (ED = 6485, HCs = 15 122)…

medicine.medical_specialtyBone densityOsteoporosis030209 endocrinology & metabolismComorbidityFeeding and Eating Disorderseating disorders (ED)Fractures Bone03 medical and health sciences0302 clinical medicineBone DensityInternal medicinemedicineHumans030212 general & internal medicineFemoral neckBulimia nervosabusiness.industryAnorexia nervosaOdds ratiomedicine.diseaseOsteopeniaPsychiatry and Mental healthEating disordersmedicine.anatomical_structureBulimia nervosaosteoporosis rateEating disordersPhysical therapyOsteoporosisAmenorrheamedicine.symptomAnorexia nervosa; Bone density; Bulimia nervosa; Eating disorders; Fractures; Psychiatry and Mental Healthbusinessmeta-analytical evidence of bonemineral density (BMD)Fracturesanorexia nervosa; bone density; bulimia nervosa; eating disorders; fracturesActa Psychiatrica Scandinavica
researchProduct

Routine cardiac troponin assessment after percutaneous coronary intervention

2019

: Although the angiographic and procedural success of percutaneous coronary intervention (PCI) is now very high, some severe complications may still develop, including periprocedural myocardial infarction (MI). An accurate diagnosis of this condition is essential for guiding the clinical management, as these patients may need a tailored management. The current recommendations for diagnosing periprocedural myocardial infarction based on the fourth universal definition appear at first sight straightforward, but the clinical and prognostic significance of routine periprocedural cardiac troponin (cTn) assessment remains uncertain. The current scientific evidence suggests that the likelihood of …

medicine.medical_specialtyCardiac troponincardiaccardiac troponin percutaneous coronary interventionmedicine.medical_treatmentMyocardial Infarction030204 cardiovascular system & hematology03 medical and health sciencesPercutaneous Coronary Intervention0302 clinical medicinePredictive Value of TestsRisk FactorsInternal medicinemedicineHumanscardiovascular diseases030212 general & internal medicineMyocardial infarctionEvidence-Based Medicinebiologybusiness.industryReproducibility of ResultsPercutaneous coronary interventionGeneral MedicineEvidence-based medicinemedicine.diseaseTroponinTroponinTreatment OutcomePredictive value of testsConventional PCIbiology.proteinCardiologyMyocardial infarction diagnosisCardiology and Cardiovascular MedicinebusinessBiomarkersJournal of Cardiovascular Medicine
researchProduct

A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin

2013

Ghrelin is a peptide hormone produced mainly in the stomach that has widespread tissue distribution and diverse hormonal, metabolic and cardiovascular activities. The circulating ghrelin concentration increases during fasting and decreases after food intake. Ghrelin secretion may thus be initiated by food intake and is possibly controlled by nutritional factors. Lean subjects have increased levels of circulating ghrelin compared with obese subjects. Recent reports show that low plasma ghrelin is associated with elevated fasting insulin levels, insulin resistance and type 2 diabetes mellitus. Factors involved in the regulation of ghrelin secretion have not yet been defined; however, it is as…

medicine.medical_specialtyCardiotonic AgentsHyperlipidemias030209 endocrinology & metabolismPeptide hormoneBiologyCardiovascular System03 medical and health sciences0302 clinical medicineInsulin resistanceInternal medicineDiabetes mellitusInsulin SecretionDrug DiscoverymedicineAnimalsHumansHypoglycemic AgentsInsulinAntiatherogenic agentHypolipidemic Agents030304 developmental biology2. Zero hungerPharmacology0303 health sciencesEvidence-Based Medicinedigestive oral and skin physiologyType 2 Diabetes MellitusLipid Metabolismmedicine.diseaseGhrelin3. Good healthEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesGastric MucosaHyperglycemiaGhrelinhormones hormone substitutes and hormone antagonistsGhrelin secretionHormoneCurrent Pharmaceutical Design
researchProduct

Is it really important for sick people to perform exercise?

2006

medicine.medical_specialtyChronic diseasebusiness.industryMEDLINEPhysical therapyReview Literature as TopicMedicinePhysical Therapy Sports Therapy and RehabilitationOrthopedics and Sports MedicineExercise therapyEvidence-based medicinebusinessQuality-adjusted life yearScandinavian Journal of Medicine and Science in Sports
researchProduct

Atherosclerosis, degenerative aortic stenosis and statins

2009

Aortic stenosis is the most common valvular heart disease among adult subjects in western countries The current treatment for aortic stenosis is aortic valve replacement. The possibility of a medical treatment that can slow the progression of aortic stenosis is very fascinating and statins have been tested to reduce the progression of degenerative aortic stenosis (DAS). The rationale for statin treatment in DAS has a deep pathophysiological substrate, in fact inflammation and lipid infiltration constitute the same histopathological pattern of both aortic stenosis and atherosclerosis and these two conditions have the same risk factors. Whether retrospective studies have shown some efficacy o…

medicine.medical_specialtyClinical BiochemistryInflammationlaw.inventionCoronary artery diseaseRandomized controlled trialAortic valve replacementlawInternal medicineDrug DiscoverymedicineAnimalsHumansPharmacologyEvidence-Based Medicinebusiness.industryvalvular heart diseaseRetrospective cohort studyAortic Valve Stenosismedicine.diseaseAtherosclerosisSettore MED/11 - Malattie Dell'Apparato Cardiovascolareatherosclerosis aortic stenosis statinStenosiscardiovascular systemCardiologyMolecular Medicinemedicine.symptomHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessCalcification
researchProduct

Use of Expert Consensus to Improve Atherogenic Dyslipidemia Management

2013

Abstract Introduction and objectives Although atherogenic dyslipidemia is a recognized cardiovascular risk factor, it is often underassessed and thus undertreated and poorly controlled in clinical practice. The objective of this study was to reach a multidisciplinary consensus for the establishment of a set of clinical recommendations on atherogenic dyslipidemia to optimize its prevention, early detection, diagnostic evaluation, therapeutic approach, and follow-up. Methods After a review of the scientific evidence, a scientific committee formulated 87 recommendations related to atherogenic dyslipidemia, which were grouped into 5 subject areas: general concepts (10 items), impact and epidemi…

medicine.medical_specialtyConsensusDelphi TechniqueGuidelines as TopicScientific evidenceTherapeutic approachRisk FactorsMultidisciplinary approachEpidemiologymedicineHumansRisk factorDyslipidemiascomputer.programming_languageAtherogenic dyslipidemiaEvidence-Based Medicinebusiness.industryExpert consensusGeneral MedicineAtherosclerosisAtherogenic dyslipidemia Cardiovascular risk Consenso Consensus Delphi Dislipemia aterogénica HDL-C LDL-C Riesgo cardiovascular high-density lipoprotein cholesterol low-density lipoprotein cholesterolCardiovascular DiseasesFamily medicinePhysical therapybusinesscomputerDelphiRevista Española de Cardiología (English Edition)
researchProduct

OARSI–OMERACT definition of relevant radiological progression in hip/knee osteoarthritis

2009

Summary Background Joint space width (JSW) evaluated in millimeters on plain X-rays is the currently optimal recognized technique to evaluate osteoarthritis (OA) structural progression. Data obtained can be presented at the group level (e.g., mean±standard deviation of the changes). Such presentation makes difficult the interpretation of the clinical relevance of the reported results. Therefore, a presentation at the individual level (e.g., % progressors) seems more attractive but requires to determining a cut-off. Several methodologies have been proposed to define cut-offs in JSW: arbitrary chosen cut-off, cut-off based on the validity to predict a relevant end-point such as the requiremen…

medicine.medical_specialtyConsensusKnee JointRadiographyBiomedical EngineeringOsteoarthritisCutoffsArticleOsteoarthritis HipRheumatologyReference ValuesReliability studyOsteoarthritisMedicineHumansMedical physicsOrthopedics and Sports MedicineReliability (statistics)Clinical Trials as Topicbusiness.industryEvidence-based medicineOsteoarthritis Kneemedicine.diseaseClinical trialRadiographyRadiological weaponPhysical therapyDisease ProgressionFeasibility StudiesHip JointJoint space widthbusinessMedline databaseOsteoarthritis and Cartilage
researchProduct

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

2018

Background and purpose: Multiple sclerosis (MS) is a complex disease of the central nervous system. As new drugs are becoming available, knowledge on diagnosis and treatment must continuously evolve. There is therefore a need for a reference tool compiling current data on benefit and safety, to aid professionals in treatment decisions and use of resources across Europe. The European Committee of Treatment and Research in Multiple Sclerosis (ECTRIMS) and the European Academy of Neurology (EAN) have joined forces to meet this need. The objective was to develop an evidence-based clinical practice guideline for the pharmacological treatment of people with MS to guide healthcare professionals in…

medicine.medical_specialtyConsensusMultiple SclerosisdemyelinatingComplex diseasedisease-modifying therapies GRADE methodology guideline Multiple sclerosis Neurology Neurology (clinical)Outcome (game theory)Pharmacological treatmentImmunomodulation03 medical and health sciences0302 clinical medicineIntervention (counseling)GRADE methodologyAgency (sociology)Nominal group techniquemedicineImmunologic FactorsRelevance (law)Humans030212 general & internal medicineneurological disorderdisease-modifying therapiesIntensive care medicineSocieties MedicaldiseaseEvidence-Based Medicinebusiness.industryMultiple sclerosisdisease-modifying treatmentGuidelinemedicine.diseaseresearch methodEuropeNeurologymultiple sclerosiFamily medicinePractice Guidelines as TopicNeurology (clinical)businessguideline030217 neurology & neurosurgeryEuropean journal of neurology
researchProduct

The Neurostimulation Appropriateness Consensus Committee (NACC) Safety Guidelines for the Reduction of Severe Neurological Injury

2016

Introduction Neurostimulation involves the implantation of devices to stimulate the brain, spinal cord, or peripheral or cranial nerves for the purpose of modulating the neural activity of the targeted structures to achieve specific therapeutic effects. Surgical placement of neurostimulation devices is associated with risks of neurologic injury, as well as possible sequelae from the local or systemic effects of the intervention. The goal of the Neurostimulation Appropriateness Consensus Committee (NACC) is to improve the safety of neurostimulation. Methods The International Neuromodulation Society (INS) is dedicated to improving neurostimulation efficacy and patient safety. Over the past tw…

medicine.medical_specialtyConsensusNeurological injurymedicine.medical_treatmentElectric Stimulation TherapyProfessional Staff Committees03 medical and health sciencesNeural activityPatient safety0302 clinical medicine030202 anesthesiologyIntervention (counseling)medicineHumansIntensive care medicineNeurostimulationEvidence-Based Medicinebusiness.industryGeneral MedicineNeuromodulation (medicine)Safety guidelinesNeurologic injuryAnesthesiology and Pain MedicineNeurologyPractice Guidelines as TopicPhysical therapyNeurology (clinical)Nervous System Diseasesbusiness030217 neurology & neurosurgeryNeuromodulation: Technology at the Neural Interface
researchProduct

Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of hemorrhoidal disease

2020

AbstractHemorrhoidal disease (HD) is the most common proctological disease in the Western countries. However, its real prevalence is underestimated due to the frequent self-medication.The aim of this consensus statement is to provide evidence-based data to allow an individualized and appropriate management and treatment of HD. The strategy used to search for evidence was based on application of electronic sources such as MEDLINE, PubMed, Cochrane Review Library, CINAHL, and EMBASE.These guidelines are inclusive and not prescriptive.The recommendations were defined and graded based on the current levels of evidence and in accordance with the criteria adopted by American College of Chest Phys…

medicine.medical_specialtyConsensuspost-operative complicationsStatement (logic)surgical treatmentIatrogenic Diseasehemorrhoidal diseaseMEDLINEconservative treatmentReviewDiseaseCINAHLHemorrhoidal diseasePostoperative complicationsHemorrhoidsPregnancymedicineHumanshemorrhoidal disease; hemorrhoids; surgical treatment; office-based procedures; post-operative complications; special conditions; conservative treatmentLigationDigestive System Surgical ProceduresAgedbusiness.industryoffice-based proceduresGastroenterologyEvidence-based medicinespecial conditionsmedicine.diseaseColorectal surgeryItalyhemorrhoidsFamily medicineFemaleSurgerybusinessColorectal SurgeryTechniques in Coloproctology
researchProduct